Why the study?
Does primary percutaneous coronary intervention improve clinical outcomes compared to fibrinolytic therapy in patients with ST elevation myocardial infarction?
Does primary percutaneous coronary intervention improve clinical outcomes compared to fibrinolytic therapy in patients with ST elevation myocardial infarction?
Primary PCI is the preferred reperfusion strategy for STEMI if available within 120 minutes, but fibrinolytic therapy remains a viable option in geographically remote areas.
Challenges routine preference for delayed pPCI; leaves open optimal reperfusion timing in remote STEMI settings.
AIM: To compare the effectiveness of primary percutaneous coronary intervention (pPCI) and fibrinolytic therapy (FL) for the acute management of ST elevation myocardial infarction (STEMI). METHODS: A review of guidelines and PubMed literature comparing clinical outcomes of patients with STEMI treated with pPCI or FL. RESULTS: Earlier trials reported reduced mortality and reinfarction with pPCI. Recent randomized data suggest similar outcomes for delayed pPCI compared with FL, especially in geographically remote areas. Guidelines recommend pPCI as the preferred reperfusion strategy for STEMI, if available within 120 mins of first medical contact. CONCLUSION: pPCI is the preferred treatment strategy for STEMI. However, FL with subsequent percutaneous coronary intervention remains a viable option for those in rural areas.
No takes yet. Share an insight, caveat, or question.
Joy et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: